Trung Hau Le Thua
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Trung Hau Le Thua has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
Albert De Mey
Brugmann University Hospital
5 shared publicationsDang Nhat Pham
Hue Central Hospital
4 shared publicationsPhuoc Quang Le
Hue Central Hospital
4 shared publicationsPhan Huy Nguyen
Hue Central Hospital
3 shared publicationsWilly D. Boeckx
Brugmann University Hospital
3 shared publicationsDuc Phu Bui
Huè University of Medicine and Pharmacy
2 shared publications
Latest Publications
- 13 September 2016
- Published by Elsevier in Journal of Hand and Microsurgery
- Vol. 07 (01) , 129-132
Missed Compartment Syndrome of the Forearm: Limb Salvage and Reconstruction
- 13 September 2016
- Published by Elsevier in Journal of Hand and Microsurgery
- Vol. 07 (01) , 129-132
Missed Compartment Syndrome of the Forearm: Limb Salvage and Reconstruction
- Open Access
- 1 March 2016
- Published by Biomedpress in Biomedical Research and Therapy
- Vol. 3 (4) , 1
CORRECTION: Mini-invasive treatment for delayed or nonunion: the use of percutaneous autologous bone marrow injection
- 1 March 2016
- Published by Biomedpress in Biomedical Research and Therapy
- Vol. 3 (4) , 1
Open AccessCORRECTION: Mini-invasive treatment for delayed or nonunion: the use of percutaneous autologous bone marrow injection
- Open Access
- 1 March 2016
- Published by Biomedpress in Biomedical Research and Therapy
- Vol. 3 (4) , 1
CORRECTION: Autologous Bone Marrow Stem Cells combined with Allograft Cancellous Bone in Treatment of Nonunion
- 1 March 2016
- Published by Biomedpress in Biomedical Research and Therapy
- Vol. 3 (4) , 1
Open AccessCORRECTION: Autologous Bone Marrow Stem Cells combined with Allograft Cancellous Bone in Treatment of Nonunion
- Open Access
- 20 December 2015
- Published by Biomedpress in Biomedical Research and Therapy
- Vol. 2 (12) , 1-9
Autologous Bone Marrow Stem Cells combined with Allograft Cancellous Bone in Treatment of Nonunion
Autologous cancellous bone graft is currently used as a gold standard method for treatment of bone nonunion. However, there is a limit to the amount of autologous cancellous bone that can be harvested and the donor site morbidity presents a major disadvantage to autologous bone grafting. Embedding viable cells within biological scaffolds appears to be extremely promising. The purpose of this study was to assess the outcome of autologous bone marrow stem cells combined with a cancellous bone allograft as compared to an autologous bone graft in the treatment of bone nonunion. Bone marrow aspiration concentrate (BMAC) was previously produced from bone marrow aspirate via a density gradient centrifugation. Autologous cancellous bone was harvested in 9 patients and applied to the nonunion site. In 18 patients of the clinical trial group after the debridement, the bone gaps were filled with a composite of BMAC and allograft cancellous bone chips (BMAC-ACB). Bone consolidation was obtained in 88.9 %, and the mean interval between the cell transplantation and union was 4.6 +/- 1.5 months in the autograft group. Bone union rate was 94.4 % in group of composite BMAC-ACB implantation. The time to union in BMAC-ACB grafting group was 3.3 +/- 0.90 months, and led to faster healing when compared to the autograft. A mean concentration of autologous progenitor cells was found to be 2.43 +/- 1.03 (x106) CD34+ cells/ml, and a mean viability of CD34+ cells was 97.97 +/- 1.47 (%). This study shows that the implantation of BMAC has presented the efficacy for treatment of nonunion and may contribute an available alternative to autologous cancellous bone graft. But large clinical application of BM-MSCs requires a more appropriate and profound scientific investigations. [Biomed Res Ther 2015; 2(12.000): 409-417
- 20 December 2015
- Published by Biomedpress in Biomedical Research and Therapy
- Vol. 2 (12) , 1-9
Open AccessAutologous Bone Marrow Stem Cells combined with Allograft Cancellous Bone in Treatment of Nonunion
Autologous cancellous bone graft is currently used as a gold standard method for treatment of bone nonunion. However, there is a limit to the amount of autologous cancellous bone that can be harvested and the donor site morbidity presents a major disadvantage to autologous bone grafting. Embedding viable cells within biological scaffolds appears to be extremely promising. The purpose of this study was to assess the outcome of autologous bone marrow stem cells combined with a cancellous bone allograft as compared to an autologous bone graft in the treatment of bone nonunion. Bone marrow aspiration concentrate (BMAC) was previously produced from bone marrow aspirate via a density gradient centrifugation. Autologous cancellous bone was harvested in 9 patients and applied to the nonunion site. In 18 patients of the clinical trial group after the debridement, the bone gaps were filled with a composite of BMAC and allograft cancellous bone chips (BMAC-ACB). Bone consolidation was obtained in 88.9 %, and the mean interval between the cell transplantation and union was 4.6 +/- 1.5 months in the autograft group. Bone union rate was 94.4 % in group of composite BMAC-ACB implantation. The time to union in BMAC-ACB grafting group was 3.3 +/- 0.90 months, and led to faster healing when compared to the autograft. A mean concentration of autologous progenitor cells was found to be 2.43 +/- 1.03 (x106) CD34+ cells/ml, and a mean viability of CD34+ cells was 97.97 +/- 1.47 (%). This study shows that the implantation of BMAC has presented the efficacy for treatment of nonunion and may contribute an available alternative to autologous cancellous bone graft. But large clinical application of BM-MSCs requires a more appropriate and profound scientific investigations. [Biomed Res Ther 2015; 2(12.000): 409-417
- 24 November 2015
- Published by Biomedpress in Biomedical Research and Therapy
- Vol. 2 (11) , 1-7
Mini-invasive treatment for delayed or nonunion: the use of percutaneous autologous bone marrow injection
Delayed union or nonunion of bone fracture is becoming less frequent, but still remains a challenging clinical problem. Autologous cancellous bone grafting that is the gold standard method, often involves donor site morbidities and complications. Once these fractures have been mechanically stabilized, other local factors should be investigated to promote delayed healing. The purpose of this study was to evaluate the initial outcome of the percutaneous injection of autologous bone marrow after concentration for the treatment of delayed or nonunion. Our subjects included 10 patients of delayed or nonunion fracture (3 female, 7 male) with an average age of 28 years. All fractures were mechanically stabilized after accident. Delayed or nonunion affected the femur in 2 patients, the tibia in 5 patients, the humerus in 2 patients, and the ulna in 1 patient. Bone marrow aspirates were obtained from both the posterior superior iliac crest. Bone marrow aspiration concentrate was produced via density gradient centrifugation. Trocars were inserted in the delayed or nonunion gap under fluoroscopic guidance. The bone marrow aspiration concentrate was injected slowly. As results, all of 10 delayed or nonunion healed after treatment with percutaneous injection of autologous bone marrow. The mean time for new bone formation was 3.3 months, for clinical union was 5.2 months, and for radiological union was 11.8 months. The current study is encouraging in the initial outcome and percutaneous bone marrow implantation could be an effective and safe treatment for delayed or nonunion. [Biomed Res Ther 2015; 2(11.000): 389-395
- 24 November 2015
- Published by Biomedpress in Biomedical Research and Therapy
- Vol. 2 (11) , 1-7
Mini-invasive treatment for delayed or nonunion: the use of percutaneous autologous bone marrow injection
Delayed union or nonunion of bone fracture is becoming less frequent, but still remains a challenging clinical problem. Autologous cancellous bone grafting that is the gold standard method, often involves donor site morbidities and complications. Once these fractures have been mechanically stabilized, other local factors should be investigated to promote delayed healing. The purpose of this study was to evaluate the initial outcome of the percutaneous injection of autologous bone marrow after concentration for the treatment of delayed or nonunion. Our subjects included 10 patients of delayed or nonunion fracture (3 female, 7 male) with an average age of 28 years. All fractures were mechanically stabilized after accident. Delayed or nonunion affected the femur in 2 patients, the tibia in 5 patients, the humerus in 2 patients, and the ulna in 1 patient. Bone marrow aspirates were obtained from both the posterior superior iliac crest. Bone marrow aspiration concentrate was produced via density gradient centrifugation. Trocars were inserted in the delayed or nonunion gap under fluoroscopic guidance. The bone marrow aspiration concentrate was injected slowly. As results, all of 10 delayed or nonunion healed after treatment with percutaneous injection of autologous bone marrow. The mean time for new bone formation was 3.3 months, for clinical union was 5.2 months, and for radiological union was 11.8 months. The current study is encouraging in the initial outcome and percutaneous bone marrow implantation could be an effective and safe treatment for delayed or nonunion. [Biomed Res Ther 2015; 2(11.000): 389-395
- 22 May 2015
- Published by Taylor & Francis in Journal of Plastic Surgery and Hand Surgery
- Vol. 49 (5) , 306-310
Free intra-osseous muscle transfer for treatment of chronic osteomyelitis
Background: Chronic osteomyelitis is still a big reconstructive challenge. Even with standard care, therapeutic failures and recurrences are common. Multiple techniques of tissue transfer have increased the success rate. This study recommends free muscle transfers into the intramedullary bone cavities for treatment of chronic osteomyelitis. Patients and methods: The review included 29 patients that were treated for chronic osteomyelitis. Osteomyelitis was located at the femur in four patients, the tibia in 22 patients, and the foot in three patients. Dead bone and scar tissue were replaced with durable free muscle flap with special attention to fill the dead space. Results: The average age of these patients was 48.5 years old (range = 23–70 years old). The average duration of osteomyelitis was 8.2 years (range = 1–45 years). Gracilis was applied in 20 cases (69%), latissimus dorsi was used in five cases (17.2%), and rectus abdominis was performed in four cases (13.8%). There was one flap failure, one partial superficial flap necrosis, two arterial thrombosis, and one venous thrombosis. All the remaining 28 muscle flaps survived. From 1–10 years follow-up, there was one recurrence of the osteomyelitis in the distal end of the intra-medullary cavity of a femur after reconstructing using the gracilis flap. Conclusion: The present study demonstrated that free intramedullary muscle transfers are effective in providing a high rate of success in the treatment of chronic osteomyelitis. The secondary filling of the intramedullary cavity after extensive removal of all infected bony sequesters has proven to give a long-term arrest of chronic osteomyelitis.
- 22 May 2015
- Published by Taylor & Francis in Journal of Plastic Surgery and Hand Surgery
- Vol. 49 (5) , 306-310
Free intra-osseous muscle transfer for treatment of chronic osteomyelitis
Background: Chronic osteomyelitis is still a big reconstructive challenge. Even with standard care, therapeutic failures and recurrences are common. Multiple techniques of tissue transfer have increased the success rate. This study recommends free muscle transfers into the intramedullary bone cavities for treatment of chronic osteomyelitis. Patients and methods: The review included 29 patients that were treated for chronic osteomyelitis. Osteomyelitis was located at the femur in four patients, the tibia in 22 patients, and the foot in three patients. Dead bone and scar tissue were replaced with durable free muscle flap with special attention to fill the dead space. Results: The average age of these patients was 48.5 years old (range = 23–70 years old). The average duration of osteomyelitis was 8.2 years (range = 1–45 years). Gracilis was applied in 20 cases (69%), latissimus dorsi was used in five cases (17.2%), and rectus abdominis was performed in four cases (13.8%). There was one flap failure, one partial superficial flap necrosis, two arterial thrombosis, and one venous thrombosis. All the remaining 28 muscle flaps survived. From 1–10 years follow-up, there was one recurrence of the osteomyelitis in the distal end of the intra-medullary cavity of a femur after reconstructing using the gracilis flap. Conclusion: The present study demonstrated that free intramedullary muscle transfers are effective in providing a high rate of success in the treatment of chronic osteomyelitis. The secondary filling of the intramedullary cavity after extensive removal of all infected bony sequesters has proven to give a long-term arrest of chronic osteomyelitis.